Announcements Trials
Browse Landscape

Status

Completed 48Recruiting 19Terminated 14Unknown 10Active not recruiting 6Not yet recruiting 4Withdrawn 2Suspended 1Enrolling by invitation 1Available 1Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 10Sarcoma 2CNS 2NET 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Pheochromocytoma 2Neuroblastoma 2Insulinoma 2Hypoglycemia 2Hyperinsulinism 2Recurrence 1Paraganglioma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Liposarcoma 1Fibrosarcoma 1Congenital Hyperinsulinism 1Beckwith-Wiedemann Syndrome 1Adenoma, Islet Cell 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Neoplasms × Endocrine × Clear all
NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡